Related Experiment Video
Updated: May 15, 2025

10:46
Size Exclusion Chromatography for Separating Extracellular Vesicles from Conditioned Cell Culture Media
Published on: May 13, 2022
3.6K
High-Throughput Extracellular Vesicle Isolation Using Plate-Based Size Exclusion Chromatography and Automation
Tal Gilboa1,2, Dmitry Ter-Ovanesyan1, Clarissa May Babila1
1Wyss Institute for Biologically Inspired Engineering, 201 Brookline Ave., Boston, Massachusetts 02215, United States.
Journal of the American Chemical Society
|April 8, 2025
Summary
We developed a plate-based, automated size exclusion chromatography (SEC) method for high-throughput isolation of extracellular vesicles (EVs) from plasma. This scalable platform enables reproducible EV biomarker discovery and diagnostics.
Area of Science:
- Biotechnology
- Nanomedicine
- Biochemistry
Background:
- Extracellular vesicles (EVs) are promising biomarkers found in biofluids like plasma.
- Current EV isolation methods, such as size exclusion chromatography (SEC), lack the throughput for clinical applications.
- Reproducible and scalable EV isolation is crucial for biomarker discovery and diagnostics.
Purpose of the Study:
- To adapt SEC into a plate-based format for increased throughput.
- To develop an automated platform for reproducible EV isolation from clinical samples.
- To enable high-throughput analysis of EV biomarkers.
Main Methods:
- Adapted SEC to a 24-well plate format using resin-packed frits.
- Optimized EV separation from free proteins (e.g., Albumin) by measuring EV markers (CD63, CD81).
- Automated the plate-based SEC process using liquid handling platforms.
Main Results:
- Demonstrated successful separation of EVs from free proteins in the 24-well plate format.
- Achieved high reproducibility with the automated platform.
- Successfully applied the automated platform to analyze tetraspanins CD63 and CD81 in plasma samples.
Conclusions:
- The developed automated, plate-based SEC method provides a scalable and reproducible solution for EV isolation.
- This platform significantly increases throughput, enabling hundreds of samples per day.
- The method facilitates EV biomarker discovery and diagnostic applications in clinical settings.

